Oggi la mia splendida nonna 85enne ha ricevuto la sua prima dose di vaccino anti-COVID, una delle quasi 50.000 persone vaccinate oggi in Italia, perché dietro ogni numero ci sono storie, persone, affetti ➡️ https://t.co/w9FjqjT1Mp #TeamVaccines
Reunión importante con la industria farmacéutica mundial. Un sector clave para nuestro proyecto de país.
Contribuye a la economía del conocimiento y ayuda a desarrollar el tejido industrial, atraer inversiones y crear empleo.
Política útil para la mayoría.
Not a 90s sitcom, but a video by the @EU_Commission to promote the Traineeship programme (from 1991)
My fav bits: the special place for the 'Spanish party' and the "you are not in Hollywood here, you are in the HQ of the Commission of the European Communities"
From lifespan to health span - we need the revised #EUPharmaStrategy to encourage innovation, ensure equal access to medicines & improve data sharing across the EU 🏥💉
Healthcare is not a cost - but rather an investment. And what greater investment can we make in our #people?
Starting now! From Crisis to Catalyst: build resilience, back innovation and boost access
If you couldn’t join us in Brussels, you can watch the event here https://t.co/VfWTft3Xlp
#WeWontRest#EFPIA22
Important meeting with members of @EFPIA Board with @MargSchinas.
The support of industrial partners will be key to a reforming 🇪🇺 pharmaceutical rules to keep the EU as a centre for innovation and to ensure patients to access essential, affordable medicines at all times.
Today, w/ @SKyriakidesEU, we exchanged views with @EFPIA board, EU’s innovative medicines industry.
Building a Health Union remains our top priority and entails a strong, vibrant and fair European pharma sector.
Affordable medicines, competitive industry.
Key takeaways of today’s session: support innovation via PPP, decrease regulatory burden, collaboration to tackle scientific barriers & discuss unmet medical needs, good policy should be anchored in reality @WA_LifeSciences 👏🏻
During #COVID19 and throughout history, women have led in healthcare provision and critical health innovations.
Today, they are a pillar of our health systems, and must be supported to continue on this path.
Delighted to speak to the #Women@LifeSciences platform today.
Kristin Thompson euroKARE, Karen Pignet-Aiach Lysogene & @SilviaEFPIA @EFPIA
@ @WA_LifeSciences event on Unmet Paediatric Medical Needs, moderated by @NathalieMoll | Regulatory hurdles one of the key things investors look at, legislation would re-motivate investors in the field